Results 151 to 160 of about 16,323,681 (398)

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Unlocking the Functional and Nutritional Potential of Microalgae Proteins in Food Systems: A Narrative Review

open access: yesFoods
As the global demand for sustainable, nutrient-rich protein sources intensifies, microalgae have emerged as a promising alternative due to their unique biochemical, environmental, and functional properties.
José A. M. Prates
doaj   +1 more source

On a solution to a functional equation

open access: yes, 2018
We offer a solution to a functional equation using properties of the Mellin transform. A new criteria for the Riemann Hypothesis is offered as an application of our main result, through a functional relationship with the Riemann xi ...
Patkowski, Alexander E
core  

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

The structural characteristics of starches and their functional properties

open access: yes, 2018
Starch is composed of amylose and amylopectin and deposited as granules of different sizes and shapes with semi-crystalline and amorphous concentric layers that show the ‘maltese cross’.
Y. I. Cornejo-Ramírez   +5 more
semanticscholar   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Cellulose nanocrystals: synthesis, functional properties, and applications

open access: yesNanotechnology, Science and Applications, 2015
Johnsy George, SN Sabapathi Food Engineering and Packaging Division, Defence Food Research Laboratory, Siddarthanagar, Mysore, Karnataka, India Abstract: Cellulose nanocrystals are unique nanomaterials derived from the most abundant and almost ...
George J, Sabapathi SN
doaj  

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Thermoresponsive Property Controlled by End-Functionalization of Poly(N-isopropylacrylamide) with Phenyl, Biphenyl, and Triphenyl Groups [PDF]

open access: bronze, 2006
Qian Duan   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy